KANSAS CITY, Mo., Jan. 31, 2018 /PRNewswire/ -- Wesley Hamilton, founder of Disabled ButNot Really, was honored with a Community Giver award and an $18,000 prize during WeWork's Creator Awards event. Hamilton is an adaptive athlete with a heart for empowering those with disabilities to overcome their challenges,
In 2012, Hamilton suffered from a spinal cord injury, which paralyzed him. He battled and overcame depression after finding his purpose: to motivate people with disabilities to know that they are not alone and that they can achieve anything. During his acceptance speech, Hamilton acknowledged WeWork's influence on his journey, "WeWork gave me a community of like-minded individuals and it helped me fulfill my mission and to create something awesome, the Disabled But Not Really Foundation."
Hamilton does not let his wheelchair keep him from accomplishing big things. Hamilton's optimistic demeanor both surprises and inspires those around him. Leadership of the WeWork Corrigan Station branch in Kansas City nominated Hamilton for the work of his foundation, Disabled But Not Really, as well as his community engagement project, Hydrate the Homeless. His new prize money will be put toward equipment for the organization's first adaptive fitness program.
About Disabled But Not Really: Founded in 2015, Disabled But Not Really is a non-profit based in Kansas City, MO with a vision to "To empower the disabled community via programs focused on health, fitness, and wellness to increase daily physical activity." To learn more, donate or volunteer, visit the website: www.disabledbutnotreally.org.
CONTACT: Wesley Hamilton, 1-816-286-3094, firstname.lastname@example.org
View original content:http://www.prnewswire.com/news-releases/philanthropist-wesley-hamilton-honored-with-wework-prize-money-300591311.html
SOURCE Disabled But Not Really Foundation
Subscribe to our Free Newsletters!
Collagen plays a crucial role in glowing skin, strong nails and shiny hair. You can boost collagen ...
CRISPR technology is a simple but potent tool for editing any part of the genome (complete set of ...
FDA recently approved Mogamulizumab-kpkc, a human monoclonal antibody prescribed for adult ...View All